» Articles » PMID: 31989042

CHL1 and NrCAM Are Primarily Expressed in Low Grade Pediatric Neuroblastoma

Overview
Journal Open Med (Wars)
Specialty General Medicine
Date 2020 Jan 29
PMID 31989042
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neural cell adhesion molecules like close homolog of L1 protein (CHL1) and neuronal glia related cell adhesion molecule (NrCAM) play an important role in development and regeneration of the central nervous system. However, they are also associated with cancerogenesis and progression in adult malignancies, thus gain increasing importance in cancer research. We therefore studied the expression of CHL1 and NrCAM according to the course of disease in children with neuroblastoma.

Methods: CHL1 and NrCAM expression levels were histologically assessed by tissue microarrays from surgically resected neuroblastoma specimens of 56 children. Expression of both markers was correlated to demographics as well as clinical data including metastatic dissemination and survival.

Results: CHL1 was expressed in 9% and NrCAM in 51% of neuroblastoma tissue samples. Expression of CHL1 was higher in patients with low Hughes grade 1a/b (p=0.01). NrCAM was more often detected in patients with a low International Staging System (INSS) score 1/2 (p=0.04).

Conclusion: CHL1 and NrCAM expression was associated with low-grade pediatric neuroblastoma. These adhesion molecules may play a role in early tumor development of neuroblastoma.

Citing Articles

Identification of effective diagnostic genes and immune cell infiltration characteristics in small cell lung cancer by integrating bioinformatics analysis and machine learning algorithms.

Chen Y, Han K, Liu Y, Wang Q, Wu Y, Chen S Saudi Med J. 2024; 45(8):771-782.

PMID: 39074893 PMC: 11288485. DOI: 10.15537/smj.2024.45.8.20240170.


CircNRCAM up-regulates NRCAM to promote papillary thyroid carcinoma progression.

Wang C, Wang Z, Fu L, Du J, Ji F, Qiu X J Endocrinol Invest. 2024; 47(5):1215-1226.

PMID: 38485895 DOI: 10.1007/s40618-023-02241-x.


Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma.

Zhou L, He L, Liu C, Qiu H, Zheng L, Sample K J Exp Clin Cancer Res. 2023; 42(1):311.

PMID: 37993901 PMC: 10664624. DOI: 10.1186/s13046-023-02893-w.


3D geometry orchestrates the transcriptional landscape of metastatic neuroblastoma cells in a multicellular bone model.

Nasehi R, Abdallah A, Pantile M, Zanon C, Vogt M, Rutten S Mater Today Bio. 2023; 19:100596.

PMID: 36910273 PMC: 9999213. DOI: 10.1016/j.mtbio.2023.100596.


Investigating SH-SY5Y Neuroblastoma Cell Surfaceome as a Model for Neuronal-Targeted Novel Therapeutic Modalities.

Gangras P, Gelfanova V, Williams G, Handelman S, Smith R, Debets M Int J Mol Sci. 2022; 23(23).

PMID: 36499391 PMC: 9739866. DOI: 10.3390/ijms232315062.


References
1.
Schmid R, Maness P . L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Curr Opin Neurobiol. 2008; 18(3):245-50. PMC: 2633433. DOI: 10.1016/j.conb.2008.07.015. View

2.
Zhu H, Fang J, Zhang J, Zhao Z, Liu L, Wang J . miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma. Biochem Biophys Res Commun. 2014; 450(1):857-62. DOI: 10.1016/j.bbrc.2014.06.073. View

3.
Chan J, Ong C, Salto-Tellez M . Overexpression of neurone glial-related cell adhesion molecule is an independent predictor of poor prognosis in advanced colorectal cancer. Cancer Sci. 2011; 102(10):1855-61. DOI: 10.1111/j.1349-7006.2011.02021.x. View

4.
Wachowiak R, Fiegel H, Kaifi J, Quaas A, Krickhahn A, Schurr P . L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors. Ann Surg Oncol. 2007; 14(12):3575-80. DOI: 10.1245/s10434-007-9608-0. View

5.
He L, Ma Q, Shi Y, Ge J, Zhao H, Li S . CHL1 is involved in human breast tumorigenesis and progression. Biochem Biophys Res Commun. 2013; 438(2):433-8. DOI: 10.1016/j.bbrc.2013.07.093. View